# Food Labeling: Health Claims; Plant Sterol/Stanol Esters and Coronary Heart Disease
> **Food and Drug Administration** · Interim final rule. · Published 2000-09-08 · Effective 2000-09-08 · 65 FR 54686
## Document
- **Document number:** 00-22892
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 65 FR 54686
- **CFR reference:** 21 CFR 101
- **Publication date:** 2000-09-08
- **Effective date:** 2000-09-08
- **HHS docket:** Docket Nos. 00P-1275 and 00P-1276
## Abstract

The Food and Drug Administration (FDA) is authorizing the use, on food labels and in food labeling, of health claims on the association between plant sterol/stanol esters and reduced risk of coronary heart disease (CHD). FDA is taking this action in response to a petition filed by Lipton (plant sterol esters petitioner) and a petition filed by McNeil Consumer Healthcare (plant stanol esters petitioner). Based on the totality of publicly available evidence, the agency has concluded that plant sterol/stanol esters may reduce the risk of CHD.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2000/09/08/00-22892/food-labeling-health-claims-plant-sterolstanol-esters-and-coronary-heart-disease)
---
*AI Analytics · CC0 1.0*